'Warburg Pincus Near Over $7 Billion Deal For Specialty-Pharmacy Company; PANTHERx Rare Has Been Owned By A Group Of Private-Equity Firms Since 2022' - WSJ Exclusive

Loading news article.

'Warburg Pincus Near Over $7 Billion Deal For Specialty-Pharmacy Company; PANTHERx Rare Has Been Owned By A Group Of Private-Equity Firms Since 2022' - WSJ Exclusive | WAPE

'Warburg Pincus Near Over $7 Billion Deal For Specialty-Pharmacy Company; PANTHERx Rare Has Been Owned By A Group Of Private-Equity Firms Since 2022' - WSJ Exclusive

Article summary

Related companies

Comments —